These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 12949537)
1. Ownership at too high a price? Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537 [No Abstract] [Full Text] [Related]
2. Biotechs sue Columbia over fourth Axel patent. Howard K Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538 [No Abstract] [Full Text] [Related]
3. US court case to define EST patentability. Lawrence S Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055 [No Abstract] [Full Text] [Related]
4. Napster case spills into biotech sector. Bouchie A Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189 [No Abstract] [Full Text] [Related]
5. Equivalents in biotechnology patents. Auer HE Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574 [No Abstract] [Full Text] [Related]
6. Biotechnology patents under fire. Royzman I Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959 [No Abstract] [Full Text] [Related]
8. The importance of getting inventorship right. Sheiness D; Canady K Nat Biotechnol; 2006 Feb; 24(2):153-4. PubMed ID: 16465154 [No Abstract] [Full Text] [Related]
9. Is the viability of the Lilly doctrine on the decline? Walker BW; Carty SM Nat Biotechnol; 2003 Aug; 21(8):943-4. PubMed ID: 12894207 [No Abstract] [Full Text] [Related]
10. Determining the meaning of claim terms. Auer HE Nat Biotechnol; 2006 Jan; 24(1):41-3. PubMed ID: 16404391 [No Abstract] [Full Text] [Related]
11. The 'Lilly doctrine' is viable and critical. Caltrider SP; Kelley JJ Nat Biotechnol; 2003 Oct; 21(10):1131-2. PubMed ID: 14520388 [No Abstract] [Full Text] [Related]
17. No room for experiment: the Federal Circuit's narrow construction of the experimental use defense. Ludwig SP; Chumney JC Nat Biotechnol; 2003 Apr; 21(4):453. PubMed ID: 12665827 [No Abstract] [Full Text] [Related]